YOU’RE A PERSON, NOT A PROSTATE CANCER STATISTIC
It’s your life and you really don’t care that you’re now a statistic and, according to the National Cancer Institute, one of 233,000 new cases of prostate cancer diagnosed this year. We get it.
At Rocky Mountain Cancer Centers our doctors have been helping men like you since 1992 fight prostate cancer and go on to live quality lives. Our doctors practice evidence-based medicine which means you will receive proven treatment that is based on scientific evidence.
Our team includes some of Colorado’s best and brightest physicians with a recognized expertise in managing prostate cancer. In addition, because we are an affiliate of The US Oncology Network, you have access to the knowledge and expertise of not only our own 58 physicians but also nearly 1,000 physicians nationwide, including some of the national leaders in the field.
Clinical research trials represent some of the most advanced treatment options. Click here to learn more.
A CANCER TREATMENT PLAN THAT WORKS FOR YOU
Our expert doctors will work with you to develop a personalized prostate cancer treatment plan based on your age, the grade of the tumor (how aggressive the tumor looks under the microscope), the stage of your disease (how far it has spread around your body, if at all), your symptoms (like erectile problems, blood in the urine, pain in the bones), and your overall general health.
Your plan may include the latest advanced treatments, including clinical research studies if you so choose. We offer the latest advances in radiation therapies, including brachytherapy, Intensity Modulated Radiation Therapy (IMRT), and Image Guided Radiation Therapy (IGRT).
Prostate cancer is highly survivable if diagnosed and treated early, before the cancer has left the prostate gland. Early detection is key, so if you have prostate cancer, encourage your male relatives to talk to their doctors about whether they should be screened.
PROSTATE CANCER TREATMENTS
RADIATION THERAPY WITH RADIUM-223
Radium-223 (Xofigo) is a relatively new treatment for prostate cancer that has spread to the bones and is resistant to chemotherapy. It is a radioactive isotope that goes to the bone and can kill cancer cells there. It prolongs survival. Both our medical oncologists and our radiation oncologists can discuss this treatment option with you.
Many times men with prostate cancer need surgery to remove the cancer. We work with some of the best urologists in Colorado to make sure you understand the surgical treatment options for your disease.
Many of our urology colleagues use the latest techniques, including the da Vinci robot, when operating on the prostate.
It has been known for decades that prostate cancer cells thrive on testosterone, and one of the most effective treatments for the disease is hormonal therapy that reduces testosterone levels. This hormonal therapy is also known as “androgen deprivation therapy.”
There are many ways that androgen deprivation therapy can be accomplished, including surgical castration, injections, or even implants under the skin. Your doctor can tell you more about these options and whether they are appropriate for you.
In addition, several newer hormonal therapies are now available for use when initial androgen deprivation therapy fails. Examples include abiraterone (Zytiga) and enzalutamide (Xtandi). Both of these drugs can delay the need for chemotherapy and prolong survival.
Prostate cancer was the first cancer in which a vaccine therapy has been shown to prolong survival. The approved vaccine is called sipuleucel-T. It is appropriate for men with cancer that has become resistant to androgen deprivation therapy, as long as they have few or no symptoms of the disease.
Peripheral blood stem cells are removed from your blood at the Bonfils blood bank and sent to a company where they are modified to be able to recognize prostate cancer cells. The modified stem cells are then reinfused into your blood, where they can attack your prostate cancer cells and help you live longer.
Chemotherapy has been an effective treatment modality for men with prostate cancer for more than a decade. Chemotherapy drugs that are commonly used include docetaxel, cabazitaxel, and mitoxantrone.
Chemotherapy is used in men with prostate cancer that is resistant to androgen deprivation therapy and has spread to other parts of the body (metastatic).